Anemia Diagnosis & Treatment: Clinical Algorithm Guide

Anemia evaluation follows a structured morphologic and etiologic approach. This guide outlines the diagnostic pathway by RBC indices.

Initial Classification by MCV

Microcytic (MCV <80 fL): Hypochromic

  1. Iron Deficiency Anemia (IDA): Most common. Confirm: Low ferritin (<30 ng/mL), high TIBC, low transferrin saturation (<16%). Trial of oral iron → reticulocytosis in 7-10 days, Hb rise in 2-3 weeks confirms.
  2. If iron replete or non-responsive:
    • Thalassemia trait: Normal/high ferritin, high RBC count, Mentzer index (MCV/RBC) <13. Confirm: Hb electrophoresis, genetic testing
    • Anemia of chronic disease (ACD): Normal/high ferritin, low TIBC, low serum iron. Often normocytic but can be microcytic.
    • Sideroblastic anemia: Ring sideroblasts on marrow; genetic or acquired (alcohol, drugs, lead)
  3. Bone marrow biopsy: If diagnosis unclear after above

Macrocytic (MCV >100 fL)

  1. Megaloblastic: B12 or folate deficiency
    • Measure serum B12, folate, methylmalonic acid (MMA), homocysteine
    • B12 deficiency: ↑MMA, ↑homocysteine; Folate deficiency: ↑homocysteine only
    • If levels borderline/normal but high suspicion → bone marrow
  2. Non-megaloblastic:
    • Alcohol, liver disease, hypothyroidism, drugs (hydroxyurea, metformin), MDS
    • Reticulocytosis (hemolysis, recovery)

Normocytic (MCV 80-100 fL)

  1. Anemia of chronic disease/inflammation (most common in hospitalized)
  2. Renal failure (EPO deficiency)
  3. Endocrine (hypothyroid, adrenal insufficiency)
  4. Early iron deficiency or mixed deficiencies
  5. Bone marrow failure (aplastic, MDS, infiltration)
  6. Hemolysis (check reticulocyte count, LDH, haptoglobin, bilirubin, DAT)
  7. Acute blood loss

Hemoglobinopathy/Thalassemia Workup

  • Hb electrophoresis/HPLC: Identifies HbS, HbC, HbE, HbF, HbA2 elevation (β-thal trait)
  • Alpha-thalassemia: Genetic testing (deletions); not on electrophoresis
  • DNA sequencing for rare mutations

Bone Marrow Indications

  • Pancytopenia or bicytopenia
  • Unexplained macrocytosis
  • Suspected MDS, leukemia, myelofibrosis, infiltration
  • Persistent anemia despite adequate treatment trial

Treatment Principles

  • Treat cause: Iron/B12/folate replacement, EPO for CKD, immunosuppression for AIHA, etc.
  • Transfusion threshold: Hb <7 g/dL (most); <8 g/dL (cardiovascular disease); symptomatic regardless of Hb
  • Monitor: Reticulocyte response, Hb trend, iron studies, B12/folate if replaced

Always correlate with clinical picture: bleeding, hemolysis, nutrition, medications, comorbidities.

Blood Disorders - Related Articles